The SCR19 peptide 1114-PIDNGDIT-1121 was previously identified as a binding site for FH-autoantibodies detected in patients with non-small cell lung cancer, and the autoantibodies recognized FH particularly when FH was reduced. This evidence concerns the gene FH and non-small cell lung carcinoma.